Janux Therapeutics (JANX) - Bozor qiymatining balans qiymatiga nisbati

JANX (Janux Therapeutics) - kompaniyaning tovar belgisi

Ushbu grafik immunologik onkologik davolash vositalarini ishlab chiqishga e'tibor qaratgan Janux Therapeutics (JANX) kompaniyasining joriy bozor qiymatini aks ettiradi, u 1.18 miqdorida qayd etilgan. Noyob IT tizimi orqali intellektual mulkni himoya qilish va sanoatdagi nufuz, FDA ning qat'iy nazoratiga qaramay, raqobatni cheklaydi. Komponentlar yetkazib berishning barqarorligi tadqiqotlar sur'atini kafolatlaydi, garchi dastlabki bosqichdagi sinovlar va mablag'larning tez sarflanishi sezilarli moliyaviy xatarlarni yuzaga keltirsa-da.

Janux Corp (JANX) Kapitallashuvning balans qiymatiga nisbati: 04.07.2022 - 29.10.2026 davri uchun
Janux Pharma ishlab chiqargan mahsulot

Ushbu ko'rsatkich Janux Therapeutics (JANX) bozor qiymatini uning sof aktivlariga solishtiradi, bu esa investorlarga spekulyativ shovqinlarni filtrlash va biznesning haqiqiy qiymatini fundamental kapital prizmasi orqali baholash imkonini beradi. Bozor qiymatining buxgalteriya qiymatiga nisbati grafigini tahlil qilish orqali, bozor hozirda kompaniyaning saraton immunoterapiyasini ishlab chiqishdagi muvaffaqiyatlarini uning haqiqiy buxgalteriya resurslariga nisbatan qanchalik baholayotganini aniqlash mumkin.

Raqobatdosh kompaniyalar tahlili

IBRX (ImmunityBio, Inc.) - Kapitallashuvning sof aktivlarga nisbati|Kapitallashuvning balans qiymatiga nisbati IMCR|Bozor qiymatining balans qiymatiga nisbati Arcus Biosciences|Bozor qiymatining balans qiymatiga koeffitsiyenti Zymeworks Inc ZYME|Bozor qiymatining balans qiymatiga nisbati Tango Pharma (TNGX)|Iovance Corp - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati IMTX (Immatics N.V.)|XNCR - Kapitallashuvning sof aktivlarga nisbati|CMPX - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Replimune Group Inc|Lyell Immunopharma Inc (LYEL) - Bozor qiymatining balans qiymatiga nisbati|IPHA (Innate Pharma S.A) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Pyxis Oncology Inc.|Bozor qiymatining balans qiymatiga koeffitsiyenti Compugen Limited CGEN|Bozor kapitallashuvining balans qiymatiga nisbati IOBT|Sutro Biopharma Inc. (STRO) - Bozor qiymatining xususiy kapitalga nisbati|MiNK - Kapitallashuvning sof aktivlarga nisbati|Werewolf Therapeutics Inc. (HOWL) - Bozor qiymatining balans qiymatiga koeffitsiyenti|IMMX: Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati ALXO (alxoncology.com)|CUE: Bozor kapitallashuvining balans qiymatiga nisbati|PDSB - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Sonnet BioTherapeutics Holdings, Inc.|Kapitallashuvning sof aktivlarga nisbati MAIA Bio (MAIA)|Bozor qiymatining balans qiymatiga nisbati Liminatus Pharma (LIMN)|Kapitallashuvning sof aktivlarga nisbati lavatherapeutics.com LVTX|NextCure - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Leap Therapeutics Inc LPTX|INTS - Bozor qiymatining balans qiymatiga nisbati|SNSE (Sensei Biotherapeutics) - Kapitallashuvning balans qiymatiga nisbati|Theriva Biologics, Inc. (TOVX) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Gritstone bio (GRTS)|Kapitallashuvning sof aktivlarga nisbati KA|NEXI - Bozor qiymatining xususiy kapitalga nisbati|Kapitallashuvning sof aktivlarga nisbati TSBX (Turnstone Biologics)|Bozor kapitallashuvining balans qiymatiga multiplikatori VCNX|Bozor kapitallashuvining balans qiymatiga nisbati HARP (Harpoon Therapeutics)